Bruker (BRKR) reported Q3 EPS of $0.66, $0.12 better than the analyst estimate of $0.54. Revenue for the quarter came in at $638.9 million versus the consensus estimate of $609.84 million.
GUIDANCE:
Bruker sees FY2022 EPS of $2.29-$2.33, versus the consensus of $2.29.